Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the rate and extent of absorption of clindamycin
300 mg capsules (test) versus Cleocin HCl (reference), administered as 1 x 300 mg capsule
under fasting conditions.